Inventor · disambiguated record
Stefan Jacobs
Also filed as: JACOBS STEFAN · JACOBS STEFAN DENIS
11 granted patents·6 pending applications·35 citations·filing 2013–2024
88Inventor score
Top patents by PatentIndex Score
17 records- 0191US10813996B2Combination therapy involving antibodies against Claudin 18.2 for treatment of cancerGANYMED PHARMACEUTICALS AG·Filed 2018·Granted Oct 27, 2020·4 cites·18 claims
- 0290US9770487B2Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic adenocarcinomaGANYMED PHARMACEUTICALS AG·Filed 2014·Granted Sep 26, 2017·11 cites·30 claims
- 0388US10314890B2Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic cancerGANYMED PHARMACEUTICALS AG·Filed 2017·Granted Jun 11, 2019·5 cites·40 claims
- 0486US10604568B2Diagnosis and therapy of cancer involving cancer stem cellsBIONTECH AG·Filed 2014·Granted Mar 31, 2020·6 cites·10 claims
- 0585US2024335533A1Combination therapy involving antibodies against claudin 18.2 for treatment of cancerASTELLAS PHARMA INC·Filed 2024·Application pending·0 cites
- 0683US9433675B2Combination therapy involving antibodies against claudin 18.2 for treatment of cancerGANYMED PHARMACEUTICALS AG·Filed 2013·Granted Sep 6, 2016·5 cites·23 claims
- 0781US2024091312A1Combination therapy involving antibodies against claudin 18.2 for treatment of cancerASTELLAS PHARMA INC·Filed 2023·Application pending·0 cites
- 0880US11541127B2Drug conjugates comprising antibodies against claudin 18.2GANYMED PHARMACEUTICALS GMBH·Filed 2016·Granted Jan 3, 2023·2 cites·28 claims
- 0979US10022444B2Combination therapy involving antibodies against Claudin 18.2 for treatment of cancerGANYMED PHARMACEUTICALS AG·Filed 2016·Granted Jul 17, 2018·2 cites·32 claims
- 1078US2024059772A1Diagnosis and therapy of cancer involving cancer stem cellsBIONTECH AG·Filed 2023·Application pending·0 cites
- 1173US11826402B2Combination therapy involving antibodies against claudin 18.2 for treatment of metastatic pancreatic adenocarcinomaASTELLAS PHARMA INC·Filed 2020·Granted Nov 28, 2023·0 cites·7 claims
- 1272US12059464B2Combination therapy involving antibodies against Claudin 18.2 for treatment of cancerASTELLAS PHARMA INC·Filed 2020·Granted Aug 13, 2024·0 cites·22 claims
- 1371US10946069B2Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic cancerASTELLAS PHARMA INC·Filed 2019·Granted Mar 16, 2021·0 cites·20 claims
- 1470US2023270878A1Drug conjugates comprising antibodies against claudin 18.2GANYMED PHARMACEUTICALS GMBH·Filed 2022·Application pending·0 cites
- 1567US11795218B2Diagnosis and therapy of cancer involving cancer stem cellsBIONTECH AG·Filed 2020·Granted Oct 24, 2023·0 cites·22 claims
- 1649US2015132253A1Combination therapy involving antibodies against claudin 18.2 for treatment of cancerGANYMED PHARMACEUTICALS AG·Filed 2013·Application pending·0 cites
- 1748US2018258180A1Combination therapy involving antibodies against claudin 18.2 for treatment of cancerGANYMED PHARMACEUTICALS AG·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stefan Jacobs files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →